AUPH News and Press, Aurinia Pharmaceuticals Inc From 11/27/21

A newly detected coronavirus variant in Africa created panic and sparked a market selloff in the holiday-shortened week. However, the developers of COVID-19 vaccines and therapeutics advanced while several common stock offerings pressured decliners. Despite the outperformance of biotech stock...

Gainers: Pasithea Therapeutics (NASDAQ:KTTA) +257%, Petros Pharmaceuticals (NASDAQ:PTPI) +73%, Gracell Biotechnologies (NASDAQ:GRCL) +64%, iSpecimen (NASDAQ:ISPC) +43%, Qualigen Therapeutics (NASDAQ:QLGN) +33%. Losers: Longeveron (NASDAQ:LGVN) -36%...

On a day when the Nasdaq and S&P 500 lost ground, oil stocks represented a rare bright spot on Monday. The sector climbed as the U.S. and OPEC+ squared off over crude supplies. ConocoPhillips (NYSE:COP), Diamondback Energy (NASDAQ:FANG), Occidental Petroleum (NYSE:OXY), Phillips 66 (NYSE:...

The last few weeks have seen a lot of buyout chatter on AUPH. The CEO made some interesting comments in this regard in their earnings call. I believe the recent drop in price may be an opportunity. For further details see: Aurinia Buyout Chatter: CEO Says To 'Read Betwee...

Aurinia won approval for Lupus Nephritis therapy LUPKYNIS in January this year, causing its share price to reach a high of $19. Analysts believe the drug can achieve >$1bn per annum sales, and longer term, $2bn may not be unrealistic. That has created a slew of recent M&A r...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Aurinia Pharma (NASDAQ: AUPH ) stock is taking a beating on Monday following a filing with the U.S. Securities and Exchange Commission (SEC) on Friday. Source: Bukhta Yurii / Shutterstock.com Let’s jump...

Shares of Aurinia Pharmaceuticals (AUPH -28.8%) are down 28% today after filing for a mixed shelf offering late Friday. The offering is for common shares, debt securities, and warrants. Some investors see the offering as sign that a potential buyout of Aurinia may not happen. Last m...

Gainers: iSpecimen (NASDAQ:ISPC) +85%. Navitas Semiconductor (NYSE:NVTSW) +29%. Vonage (NASDAQ:VG) +26%. Astra (NASDAQ:ASTR) +25%. Avaya (NYSE:AVYA) +25%. Lee Enterprises (NASDAQ:LEE) +24%. Cloopen Group (NYSE:RAAS) +24%. MultiPlan (NYSE:MPLN) +23%. Partner (NASDAQ:PTNR) +20%. Camber Energy (...

Aurinia Pharmaceuticals (NASDAQ: AUPH) stock has fallen sharply in response to a recent regulatory filing. Investors feeling queasy about the unlimited shelf registration statement that the company filed on Friday had pulled its share price down by 26.8% as of 10:49 a.m. ET Monday. ...

Gainers: iSpecimen (NASDAQ:ISPC) +120%, MultiPlan (NYSE:MPLN) +21%, Provention Bio PRVB +20%, Stoke Therapeutics (NASDAQ:STOK) +16%, Star Equity STRR +14%. Losers: Gracell Biotechnologies (NASDAQ:GRCL) -31%, Aurinia Pharmaceuticals (NASDA...